Abstract
We describe the recombinant production of the human Y1 receptor from inclusion bodies of E. coli cultures. The in vitro refolding was carried out in the presence of lipids from bovine brain extracts. Y1 receptors in brain lipids compete for cellular receptors in competitive binding experiments.
Keywords: GPCR, Y1 receptor, E. coli, in vitro folding, brain lipids
Protein & Peptide Letters
Title: Functional Characterization of the In Vitro Folded Human Y1 Receptor in Lipid Environment
Volume: 17 Issue: 5
Author(s): Susann Schimmer, Diana Lindner, Peter Schmidt, Annette G. Beck-Sickinger, Daniel Huster and Rainer Rudolph
Affiliation:
Keywords: GPCR, Y1 receptor, E. coli, in vitro folding, brain lipids
Abstract: We describe the recombinant production of the human Y1 receptor from inclusion bodies of E. coli cultures. The in vitro refolding was carried out in the presence of lipids from bovine brain extracts. Y1 receptors in brain lipids compete for cellular receptors in competitive binding experiments.
Export Options
About this article
Cite this article as:
Schimmer Susann, Lindner Diana, Schmidt Peter, G. Beck-Sickinger Annette, Huster Daniel and Rudolph Rainer, Functional Characterization of the In Vitro Folded Human Y1 Receptor in Lipid Environment, Protein & Peptide Letters 2010; 17 (5) . https://dx.doi.org/10.2174/092986610791112783
DOI https://dx.doi.org/10.2174/092986610791112783 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Relevance of the Neuropeptide Y System in the Biology of Cancer Progression
Current Topics in Medicinal Chemistry A beta oligomerization A Therapeutic Target for Alzheimers Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia
Current Cancer Therapy Reviews Silica/Ormosil SPIONs for Biomedical Applications
Current Nanoscience Anti-Cancer / Anti-Tumor
Current Bioactive Compounds Melatonin as Antioxidant Under Pathological Processes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) subject Index To Volume 2
Current Molecular Medicine Targeting Transcription Factors for Cancer Therapy
Current Pharmaceutical Design Molecular and Biological Heterogeneity in Neuroblastoma
Current Genomics Modulating the Amyloidogenesis of α-Synuclein
Current Neuropharmacology The Forkhead Transcription Factor FOXO3a Controls Microglial Inflammatory Activation and Eventual Apoptotic Injury through Caspase 3
Current Neurovascular Research Potassium Channels are a New Target Field in Anticancer Drug Design
Recent Patents on Anti-Cancer Drug Discovery Post-Translational Modifications of PTEN and their Potential Therapeutic Implications
Current Cancer Drug Targets Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application
Current Vascular Pharmacology Toxicological Profile of Therapeutic Nanodelivery Systems
Current Drug Metabolism Semaphorins and their Receptors in Stem and Cancer Cells
Current Medicinal Chemistry Discovery and Hit to Lead Optimization of Novel Combretastatin A-4 Analogues: Dependence of C-Linker Length and Hybridization
Anti-Cancer Agents in Medicinal Chemistry Novel Targets for Apoptosis Modulation: BAG3 Protein and Other Co- Chaperones
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Ion Channel Screening Technology
CNS & Neurological Disorders - Drug Targets Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System
CNS & Neurological Disorders - Drug Targets